LACLOTION SUMMARY
LAClotion™ (ammonium lactate) lotion specially formulates 12% lactic acid, neutralized with ammonium hydroxide, as ammonium lactate to provide a lotion pH of 4.5-5.5. LAClotion™ also contains light mineral oil, glyceryl stearate, PEG-100 stearate, propylene glycol, polyoxyl 40 stearate, glycerin, magnesium aluminum silicate, laureth-4, cetyl alcohol, methyl and propyl parabens, methylcellulose, and water.
LAClotion™ is indicated for the treatment of dry, scaly skin (xerosis) and ichthyosis vulgaris and for temporary relief of itching associated with these conditions.
|
|
NEWS HIGHLIGHTSMedia Articles Related to Laclotion (Ammonium Lactate Topical)
Dry Mouth (Xerostomia)
Source: MedicineNet pilocarpine Specialty [2016.02.11]
Title: Dry Mouth (Xerostomia)
Category: Diseases and Conditions
Created: 1/31/2005 12:00:00 AM
Last Editorial Review: 2/11/2016 12:00:00 AM
Published Studies Related to Laclotion (Ammonium Lactate Topical)
A randomized, double-blind, placebo-controlled study to evaluate the efficacy in AD of liquid soap containing 12% ammonium lactate + 20% urea. [2009.12]
Atopic dermatitis (AD) is a common chronic skin disease, which mainly affects children... The liquid soap was found to be effective in patients with AD, as use of this soap in patients with stable mild to moderate AD improved the parameters studied.
A double-blind clinical trial comparing the efficacy and safety of pure lanolin versus ammonium lactate 12% cream for the treatment of moderate to severe foot xerosis. [2003.01]
Xerotic skin is a pattern of reaction to a variety of disorders (eg, winter xerosis, hereditary ichthyosis) with abnormalities of desquamation in common. The trial described in this article was a double-blind randomized-comparison clinical trial investigating the effect of pure lanolin versus ammonium lactate 12% cream in treating moderate to severe foot xerosis...
Clinical evaluation of 40% urea and 12% ammonium lactate in the treatment of xerosis. [2002]
BACKGROUND: Urea and ammonium lactate are used for the treatment of xerosis, with different degrees of success. This study compares the clinical effectiveness of these two agents... DISCUSSION: At day 14 of treatment, 40% urea cream was superior to 12% ammonium lactate for most of the instrumental and clinical assessments.
Comparison of salicylic acid and urea versus ammonium lactate for the treatment of foot xerosis. A randomized, double-blind, clinical study. [1998.07]
Xerosis is defined as dehydration of skin characterized by redness, dry scaling, and fine crackling that may resemble the crackling of porcelain. The present double-blind trial was a randomized paired comparison study evaluating the keratolytic effect of 5% salicylic acid and 10% urea ointment (Kerasal) on one foot and 12% ammonium lactate lotion (Lac-Hydrin) on the other foot in mild-to-moderate xerosis...
Salicylic Acid 6% in an ammonium lactate emollient foam vehicle in the treatment of mild-to-moderate scalp psoriasis. [2011.03]
Scalp psoriasis is a common life-altering skin condition causing a great deal of distress.Salicylic acid 6% emollient foam provides a useful option in the treatment of psoriasis that is highly effective, well tolerated and acceptable to patients.
Clinical Trials Related to Laclotion (Ammonium Lactate Topical)
Effect of Hypertonic Sodium Lactate on sVCAM-1 Level as Surrogate Marker of Endothelial Capillary Leakage in Pediatric Dengue Shock Syndrome Patients (DSS) [Active, not recruiting]
Dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS) are among the leading causes
of pediatric hospitalization in Asia. Mortality rates range from 1% at centres experienced in
fluid resuscitation, to upto 44% in established shock. The mainstay of DSS treatment is
prompt, vigorous fluid resuscitation with isotonic crystalloid solutions, followed by plasma
or colloid solutions for profound or continuing shock. However, this administration is often
associated with fluid overload and induces edema in these patients.
Hence, we planned a parallel, randomized controlled trial comparing the efficacy and safety
of solution containing half molar sodium lactate (Totilac™) with standard treatment(isotonic
crystalloid Ringer's Lactate) in pediatric Dengue Shock Syndrome patients, using plasma
soluble Vascular Cell Adhesion Molecule(sVCAM-1) levels as an indicator.
Hypertonic solutions restore hemodynamic status rapidly with increased cardiac performance
and improved tissue perfusion. This is obtained with much smaller volumes. We plan to assess
the efficacy and safety of hypertonic sodium lactate in resuscitation of DHF/DSS patients.
Continuous MONItoring of Blood LActate and Glucose Levels Using a New Central Veinous Microdialysis Catheter Device [Recruiting]
Comparing the Efficacy of Ultravate Ointment in Combination With Lac-Hydrin Lotion in the Treatment of Psoriasis [Completed]
This is an investigator-masked, randomized, parallel, clinical study comparing the efficacy
of once daily versus twice daily application of Ultravate� ointment (halobetasol propionate
0. 05% ointment) in combination with Lac-Hydrin lotion (ammonium lactate topical) in the
treatment of stable plaque psoriasis. 1) Phase 1: Patients will be treated for two weeks
with combination therapy using Ultravate� ointment with Lac-Hydrin lotion and their
psoriasis plaques will be evaluated to test efficacy of the medication. Half the subjects
will be randomized to receive treatment with once a day Ultravate® ointment and twice daily
Lac-Hydrin lotion; the other half of subjects will receive twice daily Ultravate® ointment
with twice daily Lac-Hydrin lotion. Ultravate® ointment will be discontinued following two
weeks of treatment, in compliance with its FDA indication. Phase 2: The second treatment
phase will consist of a four-week observation period. Subjects will be re-randomized to
either continue using twice daily Lac-Hydrin lotion, versus no treatment. The purpose of
this second phase of the study is to investigate whether use of Lac-Hydrin monotherapy twice
daily can minimize risk of recurrence and maximize duration of therapeutic effect. Part of
this clinical study consists of the use of patient and physician satisfaction
questionnaires. These questionnaires will include questions about the satisfaction with the
formulation of each agent, questions about compliance with treatment, etc. Such questions
could be used to demonstrate patient and physician satisfaction with each agent, with
combination therapy, and to compare patient satisfaction rates among those randomized to
once daily versus twice daily application of Ultravate® ointment. The hypothesis is that
Ultravate ointment once daily in combination with Lac-Hydrin twice daily is equal in
efficacy to Ultravate ointment twice daily in combination with Lac-Hydrin twice daily.
0.5M Na Lactate Solution in Acute Heart Failure (AHF) [Completed]
The objective of this trial to see whether:
- Cardiac performance (cardiac index and secondary outcomes)can be improved in patients with
acute heart failure (AHF) and symptoms and consequences of fluid overload (pulmonary and
interstitial edema) and poor peripheral perfusion can be reduced by:
1. Providing lactate as a substrate(Improve cardiac index)
2. Simultaneously restoring optimal preload
Optimal standard treatment will be achieved in both arms with the use of current best
treatment protocol for AHF as per independent treating physician.
4. To assess effects of 0. 5M Na lactate (Totilac) on plasma and urine biological parameters
(sodium, potassium, chloride, pH, bicarb, base excess, albumin)
5. To assess effects of 0. 5M Na lactate on morbidity and mortality.
Agreement Between Arterial, Central Venous, and Peripheral Venous Lactate in the Intensive Care Unit [Not yet recruiting]
The main objective of this study is to examine the agreement between arterial, central
venous, and peripheral venous lactate values in a population of medical Intensive Care Unit
(ICU) patients.
|
|
|
|
Page last updated: 2016-02-11
|
